Arcadia Biosciences
RKDA
Revenue for Arcadia Biosciences (RKDA)
Revenue in 2023 (TTM): $5.66 M
According to Arcadia Biosciences's latest financial reports the company's current revenue (TTM
) is $5.66 M.
In 2022 the company made a revenue of $9.64 M an increase over the years 2021 revenue that were of $6.78 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Arcadia Biosciences from 2014 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $5.66 M | -41.28% |
| 2022 | $9.64 M | 42.3% |
| 2021 | $6.78 M | -15.61% |
| 2020 | $8.03 M | 587.25% |
| 2019 | $1.16 M | -20.15% |
| 2018 | $1.46 M | -63.64% |
| 2017 | $4.02 M | 26.29% |
| 2016 | $3.18 M | -41.12% |
| 2015 | $5.41 M | -22.46% |
| 2014 | $6.98 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Marrone Bio Innovations
MBII | $44.31 M | 682.17% | 🇺🇸 USA |
 Codexis
CDXS | $70.14 M | 1,138.18% | 🇺🇸 USA |
 ScottsMiracle-Gro SMG | $3.43 B | 60,537.25% | 🇺🇸 USA |
 American Vanguard AVD | $0.57 B | 10,127.20% | 🇺🇸 USA |